Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1628, 2008-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Erlotinib + gemcitabine of no value in pancreatic cancer
Inpharma, Vol. 1, Iss. 1610, 2007-01 ,pp. :
Access to resources
Recommend
Erlotinib + gemcitabine of no value in pancreatic cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 539, 2007-01 ,pp. :
UK NICE guidance on gemcitabine for pancreatic cancer
Inpharma, Vol. 1, Iss. 1289, 2001-01 ,pp. :
PEFG superior to gemcitabine for advanced pancreatic cancer
Inpharma, Vol. 1, Iss. 1499, 2005-01 ,pp. :
Gemcitabine holds its own in pancreatic cancer
Inpharma, Vol. 1, Iss. 1491, 2005-01 ,pp. :